Literature DB >> 19645703

Controlling false discoveries in multidimensional directional decisions, with applications to gene expression data on ordered categories.

Wenge Guo1, Sanat K Sarkar, Shyamal D Peddada.   

Abstract

Microarray gene expression studies over ordered categories are routinely conducted to gain insights into biological functions of genes and the underlying biological processes. Some common experiments are time-course/dose-response experiments where a tissue or cell line is exposed to different doses and/or durations of time to a chemical. A goal of such studies is to identify gene expression patterns/profiles over the ordered categories. This problem can be formulated as a multiple testing problem where for each gene the null hypothesis of no difference between the successive mean gene expressions is tested and further directional decisions are made if it is rejected. Much of the existing multiple testing procedures are devised for controlling the usual false discovery rate (FDR) rather than the mixed directional FDR (mdFDR), the expected proportion of Type I and directional errors among all rejections. Benjamini and Yekutieli (2005, Journal of the American Statistical Association 100, 71-93) proved that an augmentation of the usual Benjamini-Hochberg (BH) procedure can control the mdFDR while testing simple null hypotheses against two-sided alternatives in terms of one-dimensional parameters. In this article, we consider the problem of controlling the mdFDR involving multidimensional parameters. To deal with this problem, we develop a procedure extending that of Benjamini and Yekutieli based on the Bonferroni test for each gene. A proof is given for its mdFDR control when the underlying test statistics are independent across the genes. The results of a simulation study evaluating its performance under independence as well as under dependence of the underlying test statistics across the genes relative to other relevant procedures are reported. Finally, the proposed methodology is applied to a time-course microarray data obtained by Lobenhofer et al. (2002, Molecular Endocrinology 16, 1215-1229). We identified several important cell-cycle genes, such as DNA replication/repair gene MCM4 and replication factor subunit C2, which were not identified by the previous analyses of the same data by Lobenhofer et al. (2002) and Peddada et al. (2003, Bioinformatics 19, 834-841). Although some of our findings overlap with previous findings, we identify several other genes that complement the results of Lobenhofer et al. (2002).

Entities:  

Mesh:

Year:  2009        PMID: 19645703      PMCID: PMC2895927          DOI: 10.1111/j.1541-0420.2009.01292.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  6 in total

1.  Regulation of DNA replication fork genes by 17beta-estradiol.

Authors:  Edward K Lobenhofer; Lee Bennett; P LouAnn Cable; Leping Li; Pierre R Bushel; Cynthia A Afshari
Journal:  Mol Endocrinol       Date:  2002-06

2.  Gene selection and clustering for time-course and dose-response microarray experiments using order-restricted inference.

Authors:  Shyamal D Peddada; Edward K Lobenhofer; Leping Li; Cynthia A Afshari; Clarice R Weinberg; David M Umbach
Journal:  Bioinformatics       Date:  2003-05-01       Impact factor: 6.937

3.  Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer.

Authors:  Eiji Tamoto; Mitsuhiro Tada; Katsuhiko Murakawa; Minoru Takada; Gaku Shindo; Ken-ichi Teramoto; Akihiro Matsunaga; Kazuteru Komuro; Motoshi Kanai; Akiko Kawakami; Yoshie Fujiwara; Nozomi Kobayashi; Katsutoshi Shirata; Norihiro Nishimura; Shun-ichi Okushiba; Satoshi Kondo; Jun-ichi Hamada; Takashi Yoshiki; Tetsuya Moriuchi; Hiroyuki Katoh
Journal:  Clin Cancer Res       Date:  2004-06-01       Impact factor: 12.531

4.  Multiplicity, directional (type III) errors, and the null hypothesis.

Authors:  Juliet Popper Shaffer
Journal:  Psychol Methods       Date:  2002-09

5.  Testing for trends in dose-response microarray experiments: a comparison of several testing procedures, multiplicity and resampling-based inference.

Authors:  Dan Lin; Ziv Shkedy; Dani Yekutieli; Tomasz Burzykowski; Hinrich W H Göhlmann; An De Bondt; Tim Perera; Tamara Geerts; Luc Bijnens
Journal:  Stat Appl Genet Mol Biol       Date:  2007-10-11

6.  Tail posterior probability for inference in pairwise and multiclass gene expression data.

Authors:  N Bochkina; S Richardson
Journal:  Biometrics       Date:  2007-12       Impact factor: 2.571

  6 in total
  24 in total

1.  Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer.

Authors:  Arun R Pandiri; Robert C Sills; Vincent Ziglioli; Thai-Vu T Ton; Hue-Hua L Hong; Stephanie A Lahousse; Kevin E Gerrish; Scott S Auerbach; Keith R Shockley; Pierre R Bushel; Shyamal D Peddada; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2012-06-11       Impact factor: 1.902

2.  Hepatic transcriptomic alterations for N,N-dimethyl-p-toluidine (DMPT) and p-toluidine after 5-day exposure in rats.

Authors:  June K Dunnick; Keith R Shockley; Daniel L Morgan; Amy Brix; Gregory S Travlos; Kevin Gerrish; J Michael Sanders; T V Ton; Arun R Pandiri
Journal:  Arch Toxicol       Date:  2016-09-16       Impact factor: 5.153

3.  Gene expression of mesothelioma in vinylidene chloride-exposed F344/N rats reveal immune dysfunction, tissue damage, and inflammation pathways.

Authors:  Pamela E Blackshear; Arun R Pandiri; Hiroaki Nagai; Sachin Bhusari; Hue-Hua Hong; Thai-Vu T Ton; Natasha P Clayton; Michael Wyde; Keith R Shockley; Shyamal D Peddada; Kevin E Gerrish; Robert C Sills; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2014-06-23       Impact factor: 1.902

4.  A change-point model for identifying 3'UTR switching by next-generation RNA sequencing.

Authors:  Wei Wang; Zhi Wei; Hongzhe Li
Journal:  Bioinformatics       Date:  2014-04-11       Impact factor: 6.937

5.  Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancer.

Authors:  Mark J Hoenerhoff; Arun R Pandiri; Stephanie A Lahousse; Hu-Hua Hong; Tai-Vu Ton; Tiwanda Masinde; Scott S Auerbach; Kevin Gerrish; Pierre R Bushel; Keith R Shockley; Shyamal D Peddada; Robert C Sills
Journal:  Toxicol Pathol       Date:  2011-05-13       Impact factor: 1.902

6.  Reduced Disc Shedding and Phagocytosis of Photoreceptor Outer Segment Contributes to Kava Kava Extract-induced Retinal Degeneration in F344/N Rats.

Authors:  Haruhiro Yamashita; Mark J Hoenerhoff; Keith R Shockley; Shyamal D Peddada; Kevin E Gerrish; Deloris Sutton; Connie A Cummings; Yu Wang; Foley F Julie; Mamta Behl; Suramya Waidyanatha; Robert C Sills; Arun R Pandiri
Journal:  Toxicol Pathol       Date:  2018-05-27       Impact factor: 1.902

7.  Cross-platform comparison of microarray data using order restricted inference.

Authors:  Florian Klinglmueller; Thomas Tuechler; Martin Posch
Journal:  Bioinformatics       Date:  2011-02-10       Impact factor: 6.937

8.  F344/NTac Rats Chronically Exposed to Bromodichloroacetic Acid Develop Mammary Adenocarcinomas With Mixed Luminal/Basal Phenotype and Tgfβ Dysregulation.

Authors:  J B Harvey; H-H L Hong; S Bhusari; T-V Ton; Y Wang; J F Foley; S D Peddada; M Hooth; M DeVito; A Nyska; A R Pandiri; M J Hoenerhoff
Journal:  Vet Pathol       Date:  2015-03-02       Impact factor: 2.221

9.  Genomic Profiling Reveals Unique Molecular Alterations in Hepatoblastomas and Adjacent Hepatocellular Carcinomas in B6C3F1 Mice.

Authors:  Sachin Bhusari; Arun R Pandiri; Hiroaki Nagai; Yu Wang; Julie Foley; Hue-Hua L Hong; Thai-Vu Ton; Michael DeVito; Keith R Shockley; Shyamal D Peddada; Kevin E Gerrish; David E Malarkey; Michelle J Hooth; Robert C Sills; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2015-08-18       Impact factor: 1.902

10.  Global dysregulation of the chromosome 14q32 imprinted region in uterine carcinosarcoma.

Authors:  Eric J Devor; Jillian N DE Mik; Shyam Ramachandran; Michael J Goodheart; Kimberly K Leslie
Journal:  Exp Ther Med       Date:  2012-01-25       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.